Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

HIV treatment

Nevirapine Detailed information

About HIV
August 2021
HIV treatment

Nevirapine Factsheet

About HIV
August 2021
HIV treatment

Abacavir/lamivudine Detailed information

About HIV
August 2021
HIV treatment

Abacavir/lamivudine Factsheet

About HIV
August 2021
HIV treatment

Lamivudine Detailed information

About HIV
August 2021
HIV treatment

Emtricitabine (Emtriva) Detailed information

About HIV
August 2021
HIV treatment

Abacavir Detailed information

About HIV
August 2021
HIV treatment

Abacavir Factsheet

About HIV
August 2021
Adherence

Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions

News
20 August 2021
New & experimental HIV treatments

CytoDyn’s previous HIV filing snafu now on better course after FDA sets them straight

Editor's pick
Fierce Biotech
16 August 2021
Resistance

Transmitted Drug Resistance to Tenofovir and Emtricitabine is declining in China

Editor's pick
Infectious Disease Advisor
12 August 2021
Pharmaceutical industry

Negative innovation: when patents are bad for patients

Editor's pick
Nature
12 August 2021
Injectable & long-acting HIV treatment

New Guideline for Replacement ART: CAB/RPV LA Not for Everyone

Editor's pick
Medscape (requires free registration)
3 August 2021
Injectable & long-acting HIV treatment

A Change of Pace

Editor's pick
POZ
2 August 2021
Access to healthcare

Pricing agreement brings HIV drug darunavir within reach of LMICs

Editor's pick
Devex
29 July 2021
Antibody-based prevention

HIV vaccines and immunotherapies “would be further along” if they had the resources of COVID-19, says leading antibody researcher

News
28 July 2021
Injectable & long-acting HIV treatment

Failed viral suppression in CAB/RPV linked to 3 Risk Factors

Editor's pick
Medscape (requires free registration)
28 July 2021
Access to healthcare

Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries

Editor's pick
Clinton Health Access Initiative
28 July 2021
Improving HIV care

IAS 2021: Providing injectable HIV treatment Video

July 2021
Coronavirus

aidsmapLIVE: IAS 2021 special Video

July 2021
Support issues for children & young people

Uganda: Trial finds improving household finances linked to effective HIV treatment

Editor's pick
Avert
24 July 2021
The search for a cure

Novel dual antibody therapy partially controls virulent HIV infection in monkeys off treatment

News
23 July 2021
Injectable & long-acting HIV treatment

IAS 2021: Injectable lenacapavir for people starting HIV treatment Video

July 2021
New & experimental HIV treatments

IAS 2021: Injectable treatment for multidrug-resistant HIV Video

July 2021